
No. of Pages: 163 | Report Code: BMIRE00025506 | Category: Life Sciences
No. of Pages: 163 | Report Code: BMIRE00025506 | Category: Life Sciences
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Embolotherapy Market - By Product
1.3.2 Embolotherapy Market - By Disease Indication
1.3.3 Embolotherapy Market - By Procedure
1.3.4 Embolotherapy Market - By End User
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EMBOLOTHERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 South Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. EMBOLOTHERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EMBOLOTHERAPY MARKET - SOUTH AFRICA MARKET ANALYSIS
6.1. EMBOLOTHERAPY - SOUTH AFRICA MARKET OVERVIEW
6.2. EMBOLOTHERAPY - SOUTH AFRICA MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EMBOLIC AGENTS
7.3.1. Overview
7.3.2. Embolic Agents Market Forecast and Analysis
7.3.3. Microspheres Market
7.3.3.1. Overview
7.3.3.2. Microspheres Market Forecast and Analysis
7.3.4. Embolic Coils Market
7.3.4.1. Overview
7.3.4.2. Embolic Coils Market Forecast and Analysis
7.3.5. Liquid Embolic Agents Market
7.3.5.1. Overview
7.3.5.2. Liquid Embolic Agents Market Forecast and Analysis
7.3.6. Embolic Plug Systems Market
7.3.6.1. Overview
7.3.6.2. Embolic Plug Systems Market Forecast and Analysis
7.3.7. Detachable Balloons Market
7.3.7.1. Overview
7.3.7.2. Detachable Balloons Market Forecast and Analysis
7.4. SUPPORT DEVICES
7.4.1. Overview
7.4.2. Support Devices Market Forecast and Analysis
7.4.3. Microcatheters Market
7.4.3.1. Overview
7.4.3.2. Microcatheters Market Forecast and Analysis
7.4.4. Guidewires Market
7.4.4.1. Overview
7.4.4.2. Guidewires Market Forecast and Analysis
8. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.3.3. Liver Cancer Market
8.3.3.1. Overview
8.3.3.2. Liver Cancer Market Forecast and Analysis
8.3.4. Kidney Cancer Market
8.3.4.1. Overview
8.3.4.2. Kidney Cancer Market Forecast and Analysis
8.3.5. Other Cancers Market
8.3.5.1. Overview
8.3.5.2. Other Cancers Market Forecast and Analysis
8.4. PERIPHERAL VASCULAR DISEASE
8.4.1. Overview
8.4.2. Peripheral Vascular Disease Market Forecast and Analysis
8.5. NEUROLOGICAL DISEASES
8.5.1. Overview
8.5.2. Neurological Diseases Market Forecast and Analysis
8.6. UROLOGICAL AND NEPHROLOGICAL DISORDERS
8.6.1. Overview
8.6.2. Urological and Nephrological Disorders Market Forecast and Analysis
8.7. GASTROINTESTINAL DISORDERS
8.7.1. Overview
8.7.2. Gastrointestinal Disorders Market Forecast and Analysis
9. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – PROCEDURE
9.1. OVERVIEW
9.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
9.3. TRANSCATHETER ARTERIAL EMBOLIZATION (TAE)
9.3.1. Overview
9.3.2. Transcatheter Arterial Embolization (TAE) Market Forecast and Analysis
9.4. TRANSCATHETER ARTERIAL RADIOEMBOLIZATION (TARE)/SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
9.4.1. Overview
9.4.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) Market Forecast and Analysis
9.5. TRANSARTERIAL CHEMOEMBOLIZATION (TACE)
9.5.1. Overview
9.5.2. Transarterial Chemoembolization (TACE) Market Forecast and Analysis
10. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. AMBULATORY SURGERY CENTERS
10.4.1. Overview
10.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
10.5. OTHER END USERS
10.5.1. Overview
10.5.2. Other End Users Market Forecast and Analysis
11. IMPACT OF COVID-19 PANDEMIC ON EMBOLOTHERAPY MARKET
11.1 SOUTH AFRICA
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. EMBOLOTHERAPY MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ACANDIS GMBH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOSTON SCIENTIFIC CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. STRYKER CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. JOHNSON AND JOHNSON
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEDTRONIC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. COOK MEDICAL
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. Guerbet LLC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BALT EXTRUSION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TERUMO CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
LIST OF TABLES
Table 1.South Africa. Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2.South Africa. Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 3.South Africa. Embolotherapy Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 4.South Africa. Embolotherapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5.Organic Developments Done By Companies
Table 6.Inorganic Developments Done by Companies
Table 7.Glossary of Terms, Embolotherapy Market